Evidence map›Paper›PMID 42316051›Full record

ArticleBMC infectious diseases2026

Prevalence and determinants of tuberculosis and COVID-19 among patients with presumptive tuberculosis in a Nigerian tertiary hospital.

Moore Ikechi Mike-Ogburia, Dumdebabari Favour Precious, Favour Chigemezu Alozie, Faith Chinwe Ofurum, Deborah Erewari Israel, Deborah Bekee

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Moore Ikechi Mike-OgburiaDepartment of Medical Microbiology, Rivers State University, Port Harcourt, Nigeria. moore.mike-ogburia@ust.edu.ng.ORCID http://orcid.org/0000-0002-3122-0933
Dumdebabari Favour PreciousDepartment of Medical Microbiology, Rivers State University, Port Harcourt, Nigeria.
Favour Chigemezu AlozieDepartment of Medical Microbiology, Rivers State University, Port Harcourt, Nigeria.ORCID http://orcid.org/0009-0004-5021-6149
Faith Chinwe OfurumDepartment of Medical Microbiology, Rivers State University, Port Harcourt, Nigeria.
Deborah Erewari IsraelDepartment of Medical Microbiology, Rivers State University, Port Harcourt, Nigeria.
Deborah BekeeDepartment of Medical Microbiology, Rivers State University, Port Harcourt, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTuberculosis (TB) remains a major public health challenge in Nigeria, while the overlap between TB and coronavirus disease 2019 (COVID-19) in symptomatic patients has been less clearly described in routine clinical settings. This study assessed the prevalence and determinants of TB and COVID-19 among presumptive TB patients in a tertiary hospital in Port Harcourt, Nigeria.

methodsThis hospital-based cross-sectional study, conducted between April and August 2024, involved 242 presumptive TB patients attending Rivers State University Teaching Hospital, Port Harcourt recruited using consecutive sampling. Sociodemographic characteristics, medical-related, and behavioural/environmental data were collected using a structured interviewer-administered questionnaire, while TB and COVID-19 were assessed using Xpert Mycobacterium tuberculosis/rifampicin (Xpert MTB/RIF) assay and STANDARD Q COVID-19 Ag Test, respectively. Statistical analysis involved descriptive statistics, chi-square tests, and multivariable logistic regression analyses using GraphPad Prism 9, with statistical significance set at p ≤ 0.05.

resultsTB was detected in 21.9% of participants; however, no participant tested positive for COVID-19, yielding a COVID-19 prevalence of 0.0%, and no case of TB/COVID-19 co-infection was identified. None of the sociodemographic characteristics examined was significantly associated with TB prevalence (p > 0.05). However, contact with someone with prolonged coughing (aOR: 5.41, 95% CI: 2.55-11.70; p < 0.0001) and HIV-positive status (aOR: 3.02, 95% CI: 1.08-8.37; p = 0.0334) were significant determinants of TB infection. In addition, current smoking (aOR: 5.18, 95% CI: 1.74-15.70; p = 0.0031) and living in a densely populated area with limited ventilation (aOR: 2.82, 95% CI: 1.29-6.12; p = 0.0086) independently predicted TB infection.

conclusionsTB remains a considerable burden among presumptive TB patients in this setting, whereas no COVID-19 or TB/COVID-19 co-infection was detected during the study period. TB risk was driven mainly by exposure-related, behavioural, clinical, and environmental factors rather than sociodemographic characteristics. Strengthening routine TB screening, contact investigation, bidirectional TB/HIV services, smoking-cessation support, and interventions addressing overcrowded, poorly ventilated living conditions may improve TB control in similar high-burden settings.

Indexed as

COVID-19TuberculosisAdolescentAdultAgedCoinfectionCross-Sectional StudiesFemaleHumansMaleMiddle AgedMycobacterium tuberculosisNigeriaPrevalenceRisk FactorsSARS-CoV-2COVID-19HIVOvercrowdingPresumptive tuberculosis patientsSmokingTB/COVID-19 co-infectionTuberculosisVentilation

Identifiers

PMID42316051
PMCPMC13528095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.